Ball still in industry’s court on EU MDR changes
This article was originally published in Clinica
The vote by the European Parliament’s ENVI committee by 52 votes to 12 in favor of a raft of compromise amendments to the European Commission’s original Medical Device Regulation (MDR) proposal may feel like a body blow to the industry. But all is not lost.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.